EUVIMEDEUVIMED entdecken
Crossref

Creatinine- and cystatin C-based population pharmacokinetic models for predicting mycophenolic acid clearance in patients with autoimmune diseases

Shunsuke Nashimoto, Masashi Miyamae, Shun Onodera, Mitsuru Sugawara, Yoh Takekuma

European Journal of Clinical Pharmacology · 2026-04 · 82 (4)

DOI: 10.1007/s00228-026-04018-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 18.03.2026. Verfasst von Shunsuke Nashimoto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo, 060-0812, Japan. Hauptthemen laut MEDLINE: Cystatin C, Mycophenolic Acid, Autoimmune Diseases, Creatinine. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To quantitatively compare the effectiveness of serum creatinine- and cystatin C-based equations in population pharmacokinetic (PPK) models in predicting renal function for mycophenolic acid (MPA) clearance in patients with autoimmune diseases. METHODS: In this single-centre retrospective study, 176 plasma samples from 37 adult patients (≥ 18 years) with autoimmune diseases who received mycophenolate mofetil were analysed. Renal function was estimated using creatinine clearance (Ccr) based on the Cockcroft-Gault equation and Chronic Kidney Disease Epidemiology Collaboration equation (creatinine-, cystatin C-, and creatinine+cystatin C-based). The PPK model was developed using Phoenix NLME 8.1 software. Model diagnostics were performed using goodness-of-fit plots, and the model adequacy was assessed using visual predictive check and bootstrap methods. RESULTS: Plasma MPA concentrations were modelled using a two-compartment model with first-order elimination and a transit compartment for the absorption process. In the PPK analysis, MPA clearance was most effectively explained by the Ccr. Moreover, Ccr and albumin levels were identified as covariates significantly influencing MPA clearance. CONCLUSION: For adults with autoimmune diseases, creatinine-based equations (particularly Ccr) are superior in predicting MPA clearance. Cystatin C levels reflect glomerular filtration alone, whereas creatinine is eliminated via both glomerular filtration and tubular secretion. Since creatinine and a major MPA metabolite are eliminated by tubular secretion, Ccr is the optimal covariate in this analysis. However, cystatin C-based equations may better explain MPA clearance in paediatric patients or older adults with low muscle mass. Therefore, selecting the appropriate renal function equation according to patient characteristics is crucial for optimal mycophenolate mofetil dosing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystatin CMycophenolic AcidAutoimmune DiseasesCreatinineModels, BiologicalImmunosuppressive AgentsHumansFemaleMaleAdultMiddle AgedRetrospective StudiesAgedGlomerular Filtration RateYoung Adult

Stichwörter der Autor:innen

Autoimmune diseasesCystatin CMycophenolic acidPopulation pharmacokinetic analysisRenal clearanceSerum creatinine

Substanzen

Cystatin CMycophenolic AcidCreatinineImmunosuppressive Agents

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo, 060-0812, Japan.
  • Department of Pharmacy, Hokkaido University Hospital, Kita-14-jo, Nishi-5-chome, Kita-ku, Sapporo, 060-8648, Japan.
  • Department of Pharmacy, Hokkaido University Hospital, Kita-14-jo, Nishi-5-chome, Kita-ku, Sapporo, 060-8648, Japan. y-kuma@pharm.hokudai.ac.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Nashimoto, S., Miyamae, M., Onodera, S., Sugawara, M., & Takekuma, Y. (2026). Creatinine- and cystatin C-based population pharmacokinetic models for predicting mycophenolic acid clearance in patients with autoimmune diseases. European Journal of Clinical Pharmacology, 82(4). https://doi.org/10.1007/s00228-026-04018-6

Vancouver

Nashimoto S, Miyamae M, Onodera S, Sugawara M, Takekuma Y. Creatinine- and cystatin C-based population pharmacokinetic models for predicting mycophenolic acid clearance in patients with autoimmune diseases. European Journal of Clinical Pharmacology. 2026;82(4). doi:10.1007/s00228-026-04018-6

BibTeX
@article{Nashimoto2026,
  author = {Nashimoto, Shunsuke and Miyamae, Masashi and Onodera, Shun and Sugawara, Mitsuru and Takekuma, Yoh},
  title = {Creatinine- and cystatin C-based population pharmacokinetic models for predicting mycophenolic acid clearance in patients with autoimmune diseases},
  journal = {European Journal of Clinical Pharmacology},
  year = {2026},
  volume = {82},
  number = {4},
  doi = {10.1007/s00228-026-04018-6}
}
Kostenlos starten →